Chapter 8 discussion
8.3 study limitations
1. Routine antenatal screening should be carried out for all women at booking for antenatal care in JUTH.
2. Women who are HCV positive should be monitored closely till delivery and thereafter referred to gastroenterology clinic for onward follow.
3. The factors that determine whether or not an infant actually becomes infected need to be identified.
4. Strategy for prevention of mother to child transmission of HCV should be adopted in other to reduce the burden of new infection among children.
61
REFERENCES
1. Airoldi J., Berghella V. Hepatitis C and pregnancy. Obstet Gynaecol Surv 2006; 61:666-672.
2. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005; 41:45-51.
3. Radkowki M., Horban A., Gallegos-Orozco J.F, et al. Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels.
J Infect Dis 2005;191:1730-1733.
4. Carreño V. Occult hepatitis C virus infection: A new form of hepatitis C. World J Gastroenterol 2006;12:6922-6925.
5. World Health Organization. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Journal on Viral Hepatitis. Antwerp, Belgium. 1999; 6:35– 47.
6. American Academy of Paediatrics.Hepatitis C. In: Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed, Pickering, LK (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2009; 361.
7. Castillo I., Pardo M., Bartolomé J. et al. Occult hepatitis C virus infection in patients in whom the aetiology of persistently
62
abnormal results of liver-function tests is unknown. J Infect Dis 2004;189:7-14.
8. England K., Pembrey L., Tovo P.A., Newell M.L. European Paediatric HCV Network. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers.
ActaPaediatr 2005; 94:444-450.
9. Agbede, O.O., Iseniyi, J.O., Kolawole, M.O., Ojuowa, A. Risk factors and seroprevalence of hepatitis B surface antigenemia in mothers and their preschool age children in Ilorin, Nigeria.
Therapy. 2007; (1):67-72.
10. Mast E.E., Hwang L.Y., Seto D.S. et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192:1880-1889.
11. Sagnelli E., Coppola N., Pisaturo M. et al. Clinical and virological improvement of hepatitis B related or hepatitics C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Clin Infect Dis 2006; 42:1536-1543.
12. Radkowki M., Horban A., Gallegos-Orozco J.F. et al. Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels.
J Infect Dis 2005; 191:1730-1733.
63
13. Airoldi J., Berghella V. Hepatitis C and pregnancy. Obstet Gynecol Surv 2006;61:666-672.
14. Zahariadis G., Plitt S.S., O’Brien S., Yi Q.L., Fan W,, Preiksaitis J. K.
Prevalence and estimated incidence of blood-borne viral pathogen infection in organ and tissue donors from northern Alberta. Am J Transplant 2007; 7:226-234.
15. Mohan P., Colvin C., Glymph C. et al. Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.
J Pediatr 2007; 150:168-174.
16. Azzari C., Resti M., Moriondo M., Ferrari R., Lionetti P., Vierucci A.
Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood 2000;96:2045-2048.
17. Conte D., Fraquelli M., Prati D. et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31:751
18. Chiquete E., Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review. Intervirology 2007;50(1):1-8.
19. Onakewhor J. U., Okonofua F. E. Seroprevalence of Hepatitis C viral antibodies in pregnancy in a tertiary health facility in Nigeria.
Niger J Clin Pract. 2009; 12(1): 65–73.
64
20. Ahmedin J., Taylor., M., Ram C.T. A New Section in Cancer Offering Timely And Targeted information, A Cancer Journal for Clinicians. 2004; 54 (8):54.
21. Safir A., Levy A., Sikuler E., Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver International. 2010; 30(5): 765-770.
22. Floreani A. Viral hepatitis and pregnancy. [Review] Current Women's Health Reviews 2009;5 (1):8-13.
23. ACOG Practice Bulletin No. 86: Viral hepatitis in pregnancy.
[Review] Obstetrics and Gynecology 2007; 110 (4):941-955.
24. Abdul Qawi K., Youssef A., Metwally M.A. et al. Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants. Croatian Medical Journal 2010;51(3):219-228.
25. Duru M. U., Aluyi H. A. S., Anukam K. C. Rapid screening for co-infection of HIV and HCV in pregnant women in Benin City, Edo State, Nigeria. African Health Sciences 2009;9(3):137-142.
26. Elsheikh R., Daak A., Elsheikh M. et al. Hepatitis B virus and Hepatitis C virus in pregnant Sudanese women. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S169.
65
27. Yeung L.T., To T., King S.M., Roberts E.A. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat 2007;14:797-805.
28. Okamoto M., Nagata I., Murakami J. et al. Prospective revaluation of risk factors in mother-to-child transmission of hepatitis C virus:
high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000;182:1511-1514.
29. Azzari C., Moriondo M., Indolfi G. et al. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. Journal of Medical Virology 2008; 80(1):65-71.
30. Stoszek S. K., Abdel-Hamid M., Narooz S., et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women.
Transactions of the Royal Society of Tropical Medicine & Hygiene 2006; 100(2):102-107.
31. Berkley E., Leslie K. K., Qualls C.R. et al. Chronic hepatitis C in a high-risk pregnant population: Screening, perinatal complications and postnatal follow-up of mother and infant. Hepatology 2006;
44(4):168.
32. Mboto C.I., Andy I.E., Eni O. I., et al. Prevalence,
Sociodemographic Characteristics and Risk Factors for Hepatitis C Infection among Pregnant Women in Calabar Municipality, Nigeria.
Hepatitis Monthly 2010;10(2):116-120.
66
33. Tsiveriotis K., Siafakas N., Meletiadis J. et al. Prevalence of HBV, HCV and HIV infections among obstetrics/gynaecology patients.
Clinical Microbiology and Infection 2009;15(S4):S585.
34. Aniszewska M., Kowalik-Mikolajewska B., Pokorska-Lis M. et al.
Seroprevalence of anti-HCV in pregnant women. Risk factors of HCV infection. [Polish]. Przeglad Epidemiologiczny 2009;63 (2):293-298.
35. Jain S., Goharkhay N., Saade G., et al. Hepatitis C in pregnancy.
[Review] American Journal of Perinatology 2007;24(4):251-256.
36. Roy E., Alary M., Morissette C., et al; Surv UDI Working Group.
High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS 2007;18:23-7.
37. Maertens G., Larouze B., Delaporte, E. Seroepidemiological survey of hepatitis virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. International Virology Journal, International Journal Epidemiology. 2001;
30:872–877.
38. Egah D. Z., Banwat E. B., Audu E. S., Iya D., et al. Hepatitis B surface antigen, Hepatitis C and HIV antibodies in a low risk blood donor group, Nigeria. East Med. Health J. 3007; 13: 211-215.
39. Ebie J. C., Pela O. A. Some sociocultural aspects of the problem of drug abuse in Nigeria. Drug and Alc. Dep. 2006; 8: 301-306.
67
40. Florida M., Tamburrini E., Anzidei G., et al. Declining HCV seroprevalence in pregnant women with HIV. Epidemiology and Infection 2010; 138 (9):1317-21.
41. Agarry O. O., Lekwot G. Z. Prevalence of hepatitis B virus and hepatitis C virus in ante-natal patients in Gwagwalada- Abuja, Nigeria. Report and Opinion 2010;2(7): 48-50.
42. Ogunro P. S., Adekanle D. A., Fadero F. F. et al. Prevalence of anti-hepatitis C virus antibodies in pregnant women and their offspring in a tertiary hospital in South-western Nigeria. Journal of Infection in Developing Countries 2007;1(3):333-6.
43. Baba M.M., Onwuka, I. S., Baba S.S. Hepatitis B and C virus infections among pregnant women in Maiduguri, Nigeria. Central European Journal of Public Health; ISSN 1210-7778, 1999; 7(2):
60-62.
44. Bruguera M., Forns X. Hepatitis C in Spain. Medicina Clinica 2006;
127(3):113-17.
45. Pennesi P., Cataldi U., Vizzaccaro F. Sero-placentarviremia and mother-to-infant transmission of the hepatitis C virus. Giornale Italiano di Ostetricia e Ginecologia 2005; 27(3):73-76.
46. Rogstad K., Thomas A., Williams O. et al. UK national guideline on the management of sexually transmitted infections and related conditions in children and young people. International Journal of STD and AIDS 2010;21 (4):229-41.
68
47. Lassey A. T., Damale N. K., Bekoe V., Klufio C.A. Hepatitis C virus seroprevalence among mothers delivering at the Korle-bu Teaching Hospital, Ghana. East African Medical Journal. 2004;
81(4): 198-201.
48. Ahmed RE, Karsany MS, Adam I. Brief report: Acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. Journal of Medical Virology2008;80(10):1747-1748.
49. Aziz S., Hossain N., Aziz Karim S. et al. Vertical transmission of HCV in middle and low socio economic population of Karachi.
International Journal of Gynecology and Obstetrics 2009;107 (Suppl 2):S114.
50. Sookoian S. Effect of pregnancy on pre-existing liver disease:
chronic viral hepatitis. Annals of Hepatology 2006;5 (3):190-197.
51. Ndong-Atome G. R., Makuwa M., Njouom R. et al. Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa. BMC Infectious Diseases 2008;8:82.
52. Tiruneh M. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia. Ethiopian Medical Journal 2008;
46(4):359-66.
53. Chang M.H., Hadzic D., Rouassant S.H., et al. Acute and chronic hepatitis: Working Group Report of the Second World Congress of
69
Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition 2004; 39:S584-S588.
54. Aniszewska M., Kowalik-Mikolajewska B., Pokorska-Lis M., et al.
HCV infection in a sample of pregnant women in central Poland:
Seroprevalence and risk factors. Retrovirology 2009; 6 (Suppl 1):P6.
55. McIntyre P.G., Tosh K., McGuire W. Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database of Systematic Reviews. 2006(4).
56. Landes M., Newell M.L., Barlow P. et al. Hepatitis B or hepatitis C coinfection in HIV-infected pregnant women in Europe. HIV Medicine 2008; 9(7):526-534.
57. Iorio R., Giannattasio A., Sepe A., Terracciano L. M., Vecchione R., Vegnente A. Chronic hepatitis C in childhood: An 18-year experience. Clin Infect Dis 2005;41:1431-1437.
58. Liu A.J.W., An E.I., Murray H.G. et al. Screening for hepatitis C virus infection in methadone-maintained mothers and their infants.
Medical Journal of Australia 2009; 191(10):535-38.
59. Pergam S. A., Wang C. C., Gardella C. M., et al. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. American Journal of Obstetrics and Gynecology 2008; 199 (1): 874-877.
70
60. Minola E., Maccabruni A., Pacati I., Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. HEPATOLOGY 2001;33:1341-1342.
61. Claret G, Noguera A, Esteva C, et al. Mother-to-child transmission of hepatitis C virus infection in Barcelona, Spain: a prospective study. European Journal of Pediatrics2007;166(12):1297-1299.
62. Kumar A., Sharma K.A., Gupta R.K. et al. Pregnancy outcome in hepatitis C virus infection. International Journal of Gynaecology &
Obstetrics 2007;98(2):155-56.
63. Daniel I. Jos and Plateau. Cliff Missen, 2002.Available at http://www.widernet.org/Jos project/Jos Plateau html.(Accessed on June 5, 2012).
64. Gulfareen H., Nishat Z., Aftab A.M. Hepatitis C: frequency, risk factors and pregnancy outcome. Journal of surgery Pakistan (international). 2009; 14(1): 33-37.
65. Grace R.P., Aliyu Y., Odula O., Joseph F. Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. African Journal of Microbiology Research. 2010; 4 (4):
274-278.
66. Strickland G.T. HCV in developing Countries. Postgrad.Doc.
(Africa). 2002; 4: 18-20
67. Wasley A.D., Alter M.J. Epidemiology of of hepatitis C. Semin Liver Dis 2000; 20: 1-16.
71
68. Zuccotti G. V., Ribero M. L., Giovannini M., Fasola M., et al. Effect of hepatitis C genotype on mother-to-infanttransmission of virus. J Pediatr 1995;127:278-280.
69. Elsheikh R. M., Daak A. A., Elsheikh M.A., et al. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virology Journal 2007; 4.
70. Hutchinson S.J., Goldberg D.J., King M., et al. Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis. Gut 2004; 53(4):593-98.
71. Bruguera M., Forns X. Hepatitis C in Spain [Spanish].
MedicinaClinica2006; 127(3):113-17.
72. Sy T, Jamal MM (2006). Epidemiology of Hepatitis C virus (HCV) infection.Int. J. Med. Sci. 3: 41 -46.
73. Koate B. B., Buseri F. I., Jeremiah Z. Seroprevalence of Hepatitis C virus among blood donors in Rivers State, Nigeria. Trans. Med.
2005; 15: 449-451.
74. Sahajian F., Venhems P., Bailly F., Fabry J., et al. Screening campaign of Hepatitis C among underprivileged people consulting in health centres of Lyon area, France. Eur. J. Pub. Health.2007;
17: 263-271.
75. Garland S. M., Tabrizi S., Robinson P. et al. Hepatitis C. Role of perinatal transmission. Aust N. Z. J Obstet Gynaecol. 1998; 38 (4):424–47.
72
APPENDIX I
HEPATITIS C VIRUS INFECTION AMONG PARTURIENT DELIVERING AT JOS UNIVERSITY TEACHING HOSPITAL AND THE RISK OF MOTHER TO CHILD TRANSMISSION
CONSENT FORM
I, Dr. Onoja Kate Omonlei, a senior registrar in the department of Obstetrics and Gynaecology of JUTH, am conducting a research on hepatitis c virus infection among parturient delivering at Jos University Teaching Hospital and the risk of mother to child transmission in Jos University Teaching Hospital (JUTH), Jos.
About 5mls of blood will be collected from you and the babies of those found to be HCV positive and sent to the laboratory and tested for HCV infection.
The knowledge of this will help the health care system to know how to counsel women on the dangers of teenage pregnancy. You should feel free to participate or decline to do so. Your refusal to participate will not in any way compromise the quality of service or care you will receive at any service point in JUTH.
Any information you give in the course of our interaction will be treated with utmost confidentiality.
I, (initials only)……… hereby give consent to participate in this study.
……….….. ……….
Initials/ Signature /thumb print of individual Date
……… ………..
Initials/ Signature /thumb print of investigator Date
73
APPENDIX II
HEPATITIS C VIRUS INFECTION AMONG PARTURIENT DELIVERING AT JOS UNIVERSITY TEACHING HOSPITAL AND
THE RISK OF MOTHER TO CHILD TRANSMISSION PROFORMA:
1. Serial No………
2. Age (years) ……….
3. Ethnicity
(a) Yoruba (b) Igbo (c) Hausa (d) Other (Specify)………
4. Religion
(a) Christianity (b) Islam (c) Others (specify) ………
5. Educational level
(a) None (b) Primary (c) Secondary (d) Tertiary 6. Marital status
(a) Single (b) Married (c) Divorce (d) Separated (e) Widowed 7 Marital setting
(a) Monogamous (b) Polygamous 8. Employment Status
(a) House wife (b) Student (c) Self employed (d) Private employed (e) Government employed
9. Booking status
(a) Booked (b) Unbooked
10. Gestational age at delivery (weeks) ………
11. History of previous tattooing (a) Yes (b) No
74
12. Previous/current intravenous drug use (a) Yes (b) No
13. Previous blood transfusion (a) Yes (b) No 14. Mode of delivery
i. Normal vaginal delivery (a) Yes (b) No ii. Vacuum delivery (a) Yes (b) No
iii. Forceps delivery (a) Yes (b) No iv. Caesarean section (a) Yes (b) No 15. Foetal outcome
a. Birth weight (Kg)……….
b. APGAR scores
1 minute ………..
5 minutes ……….
c. Stillbirth (a) Yes (b) No
d. Foetal Malformation (a) Yes (b) No Type………
16. HCV status of mother